Menstrual state should be considered in determining sero-positivity of soluble angiogenic factors in breast cancer.

  • Authors:
    • H C Chung
    • S Y Rha
    • J B Ahn
    • K Y Shim
    • N C Yoo
    • J H Kim
    • J K Roh
    • K S Lee
    • J S Min
    • B S Kim
    • J J Kim
  • View Affiliations

  • Published online on: October 1, 1998     https://doi.org/10.3892/ijmm.2.4.465
  • Pages: 465-535
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

We investigated whether blood angiogenic factor (vascular endothelial growth factor, VEGF; angiogenin; basic fibroblast growth factor, bFGF; platelet-derived growth factor-AB, PDGF-AB) levels change during menstrual cycle of healthy premenopausal females or after menopause. We also measured the serum angiogenic factor levels in 34 operable breast cancer patients and compared them to those of healthy volunteer controls. No differences in the four angiogenic factor levels were found between the follicular and luteal phases of normal menstruation. However, angiogenin and bFGF levels were higher in pre-menopausal females than post-menopausal female and young male healthy volunteers. In cancer patients, the sero-positivity rate of the bFGF was 8.8% with menstrual-state-unmatched cut-off points, which increased to 36.4% with menstrual-state-matched cut-off points. This discrepancy was especially high in post-menopausal cancer patients. In conclusion, physiological elevation of the bFGF during normal menstruation can influence the precise interpretation of the pathological elevation of the bFGF in pre-menopausal breast cancer patients.

Related Articles

Journal Cover

Oct 1998
Volume 2 Issue 4

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chung H, Rha S, Ahn J, Shim K, Yoo N, Kim J, Roh J, Lee K, Min J, Kim B, Kim B, et al: Menstrual state should be considered in determining sero-positivity of soluble angiogenic factors in breast cancer.. Int J Mol Med 2: 465-535, 1998
APA
Chung, H., Rha, S., Ahn, J., Shim, K., Yoo, N., Kim, J. ... Kim, J. (1998). Menstrual state should be considered in determining sero-positivity of soluble angiogenic factors in breast cancer.. International Journal of Molecular Medicine, 2, 465-535. https://doi.org/10.3892/ijmm.2.4.465
MLA
Chung, H., Rha, S., Ahn, J., Shim, K., Yoo, N., Kim, J., Roh, J., Lee, K., Min, J., Kim, B., Kim, J."Menstrual state should be considered in determining sero-positivity of soluble angiogenic factors in breast cancer.". International Journal of Molecular Medicine 2.4 (1998): 465-535.
Chicago
Chung, H., Rha, S., Ahn, J., Shim, K., Yoo, N., Kim, J., Roh, J., Lee, K., Min, J., Kim, B., Kim, J."Menstrual state should be considered in determining sero-positivity of soluble angiogenic factors in breast cancer.". International Journal of Molecular Medicine 2, no. 4 (1998): 465-535. https://doi.org/10.3892/ijmm.2.4.465